Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCR001 for tolerance in living donor kidney transplant recipients
NCT01649388Phase 2Withdrawn
- Sponsor
- Talaris Therapeutics
- Start
- Oct 2012
- Primary completion
- Feb 2023
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
A Phase 2 trial of FCR001 in kidney transplant rejection, sponsored by Talaris Therapeutics. Planned start Oct 2012; status: withdrawn.
02
Drugs
FCR001
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01649388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01649388.